News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Iframe sync Post Navigation Previous Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories EHR Healthcare Hospitals News Patient Care AirStrip® Introduces Alarm Management: A Game-Changing FDA Approved Integrated Platform Transforming Clinical Alarm Management of Vital Signs Staff May 27, 2025 News Pharmaceutical Vaccine Rapid Dose Announces Proposed Equity Private Placement Financing Staff May 27, 2025 Cancer EHR News AI-Powered Wearable Cuts Cancer Deaths by 90%— Redefines Infection Detection in Chemotherapy Staff May 27, 2025
